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Abstract
Background: Little is known regarding mechanistic and phenotypic differences between cough
variant asthma (CVA), presenting with a chronic cough as the sole symptom that responds to
bronchodilators, and classic asthma with wheezing during methacholine inhalation. Here we
reported airway sensitivity, airway reactivity, and as the main concern, the appearance of cough and
wheezes during methacholine inhalation in patients with CVA or classic asthma.
Methods: We cross-sectionally examined the degrees of airway sensitivity, the point where
resistance started to increase, and reactivity, the slope of the methacholine-resistance curve, and
the appearance of cough and wheezes in steroid-naïve adult patients with classic asthma (n = 58)
or CVA (n = 55) while they were continuously inhaling methacholine during simultaneous
measurement of respiratory resistance.
Results: Patients with CVA were less sensitive and less reactive to inhaled methacholine and
wheezed less frequently but coughed more frequently during methacholine-induced
bronchoconstriction than did patients with classic asthma. Multivariate analysis revealed that airway
hypersensitivity and lower baseline FEV1/FVC were associated with the appearance of wheezes,
whereas a diagnosis of CVA was associated with coughing.
Conclusion: There are mechanistic and phenotypic differences between CVA and classic asthma
during methacholine inhalation. Frequent coughing during bronchoconstriction may be a distinctive
feature of CVA.
Background
Patients with cough variant asthma (CVA) present with a
chronic cough as the sole symptom that responds to bron-
chodilator treatment and show airway hyperresponsive-
ness (AHR). CVA, one of the most common causes of
chronic cough [1-4], is considered a precursor [5-9] and a
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variant form of classic asthma with typical symptoms of
wheezing and dyspnea [5]. Several studies have examined
mechanistic differences between CVA and classic asthma.
Airway sensitivity, a component of airway responsiveness
that is defined as the inflection point where respiratory
resistance (Rrs) starts to increase, did not differ between
patients with CVA and those with classic asthma in a few
small studies [10,11]. In contrast, airway reactivity,
another component of airway responsiveness expressed as
the slope of the dose-response curve, is attenuated in chil-
dren with CVA as compared with those with classic
asthma [12]. In adults with CVA, however, no study has
separately examined airway sensitivity and reactivity in a
large number of patients.
Methacholine, a non-specific cholinergic stimulant,
induces bronchoconstriction without exacerbating airway
inflammation. Apart from an analysis of mechanistic
aspects, analyses of phenotypes, such as the appearance of
cough and wheezes during methacholine-induced bron-
choconstriction, may provide clues to understanding the
unique features of CVA. To our knowledge, however, such
an approach has not been attempted thus far. In one study
in asthmatic children, detection of wheezes during meth-
acholine inhalation depended on the degree of airway
narrowing, while factors related to coughing during meth-
acholine inhalation were not specified [13].
In this study, we initially examined airway sensitivity and
reactivity to methacholine in adults with CVA and in
those with classic asthma, using a continuous inhalation
method that can separately evaluate these two compo-
nents [12,14]. Our major concern was the presence or
absence of cough and wheezes during methacholine-
induced bronchoconstriction. Factors associated with the
appearance of cough and wheezes were then analyzed.
Methods
Study subjects and design
We cross-sectionally studied adults with classic asthma (n
= 58) or with CVA (55) who presented at the outpatient
clinic of Kyoto University Hospital from April 1993 to
September 2001. Classic asthma was diagnosed according
to the American Thoracic Society criteria [15]: the symp-
toms of episodic wheezing and dyspnea within the previ-
ous year that responds to bronchodilators, and AHR to
methacholine inhalation.
CVA was diagnosed according to the following criteria
[5,10]: an isolated chronic cough without wheezing or
dyspnea that had persisted for more than 8 weeks, AHR to
methacholine, and symptomatic improvement of cough-
ing in response to inhaled beta-2  agonists, sustained-
release theophylline, or both. Wheezing or rhonchi were
not audible on chest auscultation, even with forced expi-
ration. No patient had a past history of asthma or had an
upper respiratory tract infection within the past 8 weeks.
No other apparent causes of chronic cough, such as gas-
troesophageal reflux, chronic sinusitis, or medication
with angiotensin-converting enzyme inhibitors, were
present. Patients with CVA had normal chest radiographs
and were steroid-naïve, similar to those with classic
asthma. The ethics committee of our institution approved
the study protocol, and written informed consent was
obtained from each participant.
Pulmonary function test and methacholine challenge test
Prebronchodilator FEV1  was tested using a spirometer
(Chestac-65V, Chest, Tokyo, Japan) according to the
standards of the American Thoracic Society [16].
Airway responsiveness was tested by directly recording a
dose-response curve of Rrs (cmH2O/L/sec) during contin-
uous inhalation of methacholine in two-fold incremental
concentrations (49 to 25,000 μg/ml) under tidal breath-
ing from nebulizers with an output of 0.15 ml/minute
(Astograph™; Chest, Tokyo, Japan), as described previ-
ously in detail [14,17]. If bronchodilators were being
used, their use was suspended 24 hours before the meth-
acholine inhalation. In short, after we recorded the base-
line Rrs during inhalation of physiologic saline for 1
minute, patients inhaled methacholine, starting with the
lowest concentration, at 1-minute intervals. The index of
airway sensitivity that we adopted was Dmin: the cumula-
tive dose of inhaled methacholine at the inflection point
where which Rrs began to increase continuously. One unit
of Dmin is equivalent to dose of 1 mg/ml of methacholine
inhalation for one minute. Inhalation of methacholine
was discontinued, and switched to bronchodilator inhala-
tion when Rrs reached twice the baseline value. The pla-
teau of the dose-response curve was not, therefore,
examined. The slope of the methacholine-Rrs dose-
response curve (SRrs) was used as an index of airway reac-
tivity. FEV1 was not measured after the methacholine
challenge test since holding the administration of a bron-
chodilator and addition of forced expiratory maneuver
might induce severe bronchoconstriction.
Appearance of cough and wheezes during the 
methacholine challenge test
Cough was considered to have appeared during the meth-
acholine inhalation when patients coughed one or more
times after the inflection point of Dmin. Cough before the
point of Dmin, if any, was also documented. Coughing
caused a transient spike-shape increase in Rrs, but it did
not interfere with the determination of the inflection
point or the slope of the dose-response curve. When the
methacholine inhalation was discontinued and switched
to bronchodilator inhalation, whether wheezing was
audible on auscultation was assessed by either of theCough 2009, 5:3 http://www.coughjournal.com/content/5/1/3
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attending physicians (AN, HM). The assessment of cough
or wheezes was performed in a blinded manner.
Capsaicin cough sensitivity test
In 18 patients with classic asthma and in 22 with CVA,
cough sensitivity test in addition to methacholine inhala-
tion test was done one to two weeks apart. Cough sensitiv-
ity was tested by a continuous inhalation method of
capsaicin solution using the Astograph™ as described pre-
viously [18]. Ten doubling concentrations of capsaicin
solution (0.61–312 μM) were inhaled until 5 or more
coughs were induced (cough threshold, C5). Each concen-
tration of capsaicin was inhaled for 15 seconds during
tidal breathing every 60 seconds. Remaining patients were
not examined for capsaicin cough sensitivity because
informed consents for the test were not obtained mostly
due to time constraint.
Statistical analysis
Data were analyzed using GraphPad Prism 4.00 (Graph-
Pad Software, Inc., La Jolla, CA, USA) and StatView soft-
ware 5.0 (SAS Institute Inc, Cary, NC, USA). To compare
the two patient groups, the t-test was used when data were
normally distributed, and the Mann-Whitney test was
used for nonparametric data. The χ2 test was used for the
comparisons of nominal data between groups. Univariate
and stepwise multivariate regression analyses were per-
formed to test for independent effects of disease diagno-
sis, blood eosinophil counts, atopic status, FEV1/FVC,
current smoking, log Dmin, and SRrs levels on the appear-
ance of cough or wheezes during methacholine inhala-
tion, setting the absence of cough or wheezes as 0 and the
presence as 1. We did not include C5 levels as an inde-
pendent variable since less than half of the patients under-
went the capsaicin cough sensitivity test. For inclusion of
variables into multivariate analyses, the F value, a measure
of the extent to which a variable makes a unique contribu-
tion to the prediction of the dependent variable, was set at
4.0. Data are expressed as means ± SD. We considered p
values of < 0.05 to indicate statistical significance.
Results
Patients' characteristics are shown in Table 1. As com-
pared with classic asthma group, CVA group included
fewer smokers, had a lower blood eosinophil count, a
higher baseline FEV1/FVC value, a lower baseline Rrs
value, and less sensitivity and less reactivity to inhaled
methacholine.
As for phenotypic characteristics during methacholine-
induced bronchoconstriction, cough appeared in 19
patients (35%) in the CVA group and 10 (17%) in the
classic asthma group (p = 0.035), whereas wheezes were
detected at the end of inhalation in 9 patients (16%) in
the CVA group and 28 (48%) in the classic asthma group
(p = 0.0003). Four patients with CVA started to cough
before the inflection point of Dmin. In three of these
patients, cough was relieved when methacholine was
switched to a bronchodilator, associated with a two-fold
increase in Rrs from baseline. Multivariate analyses of the
appearance of wheezes and cough showed that lower
baseline FEV1/FVC and airway hypersensitivity were inde-
pendently associated with the detection of wheezes (Table
2), whereas the appearance of cough was solely associated
with a diagnosis of CVA (Table 3). These results were
unchanged even when four patients with CVA who started
to cough before the inflection point of Dmin were
excluded from the analyses.
Table 1: Patients' characteristics
Classic asthma Cough variant asthma p-value
n = 58 n = 55
Age (yr) 44.4 ± 15.9 43.2 ± 16.5 0.71
Male/Female (No) 29/29 33/22 0.29
Disease duration at diagnosis (yr) 6.7 ± 10.0 2.8 ± 4.4 0.10
Current smoking (Yes, %) 19.0 5.2 0.029
Atopic status* (Yes, %) 71.4 67.9 0.69
Blood eosinophils (number/μl) 389 ± 247 310 ± 404 0.011
FEV1 (% predicted) 86.8 ± 19.2 92.1 ± 17.6 0.14
FEV1/FVC (%) 72.6 ± 11.3 81.8 ± 8.9 < 0.0001
Baseline Rrs (cm H2O/L/sec) 4.3 ± 2.0 4.0 ± 3.2 0.040
Log Dmin (units) -0.20 ± 0.82 0.36 ± 0.60 < 0.0001
SRrs (cm H2O/L/sec/min) 2.9 ± 3.2 2.1 ± 2.1 0.042
Log C5 (μM) 1.51 ± 0.79 (n = 18) 1.17 ± 0.71 (n = 22) 0.15
Values are given as the means ± SD.
*: measured in 56 patients with classic asthma and 53 patients with cough variant asthma. Patients were considered atopic when 1 or more specific 
IgE antibodies were positive for cat dander, dog dander, weed, grass pollen, mold, or house dust mite.
Abbreviation: Rrs, respiratory resistance. Dmin, cumulative dose of inhaled methacholine at the inflection point, where which respiratory resistance 
begins to increase. SRrs, slope of the methacholine dose-response curve for Rrs. C5, cough threshold, the lowest concentration of capsaicin that 
induces 5 or more cough.Cough 2009, 5:3 http://www.coughjournal.com/content/5/1/3
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Cough sensitivity did not differ between patients with
classic asthma (n = 18) and those with CVA (n = 22)
(Table 1). However, in CVA group 9 patients who
coughed during the methacholine-induced bronchocon-
striction showed more enhanced cough sensitivity to
inhaled capsaicin (log C5, 0.72 ± 0.65 μM) than 13 non-
coughers (1.48 ± 0.58 μM)(p = 0.015). Meanwhile, 2
coughers and 16 non-coughers in classic asthma group
did not differ in their cough sensitivity (0.69 ± 0.85 μM;
1.62 ± 0.75 μM, respectively)(p = 0.12).
Discussion
To our knowledge, this is the first study to comprehen-
sively examine mechanistic and phenotypic differences
during methacholine inhalation between adults with CVA
and those with classic asthma. Patients with CVA were less
sensitive and less reactive to inhaled methacholine than
were those with classic asthma. Coughing was more fre-
quent during methacholine-induced bronchoconstriction
in the CVA group, whereas wheezes were more frequent in
the classic asthma group at the end of methacholine inha-
lation. Multivariate analysis of factors related to cough
and wheezes revealed that wheezes were associated with
airway hypersensitivity and baseline airflow obstruction,
whereas cough triggered by bronchoconstriction was
related to CVA.
Airway sensitivity and reactivity are thought to be differ-
ently regulated [19,20]. Airway sensitivity is most likely
associated with airway inflammation, epithelial damage
or malfunction, abnormal neural control, and increased
inflammatory cell number and activity. In contrast, airway
reactivity is considered most strongly related to smooth
muscle contractility. Airway sensitivity was substantially
lower in patients with CVA than in those with classic
asthma. Previous studies showed no significant difference
in airway sensitivity between these two asthmatic condi-
tions [10-12,21]. The discrepancy may be attributed to
differences in patient selection [10-12,21] and methodol-
ogy [21]. Children with CVA were studied by Koh et al
[21] and Mochizuki et al [12]. The airway physiology of
children may differ from that of adults, as suggested by
differences between mature and immature animals in the
responses of airway smooth muscle to cholinergic stimu-
lation [22]. In previous studies of adults with CVA (n =
14) [10], (n = 10) [11], sample sizes were relatively small.
In addition, our previous study was conducted in patients
with CVA who agreed to be hospitalized and to undergo
bronchoscopic examination [10], conditions that might
Table 2: Univariate and multivariate regression analysis of appearance of wheezes
Univariate analysis
Correlation coefficient
P Wheezes
Standardized partial regression coefficient
F value
Disease 0.34 0.0002 not entered < 4.0
Blood eosinophils (number/μl) 0.11 0.35 not entered < 4.0
Atopy -0.05 0.60 not entered < 4.0
Baseline FEV1/FVC (%) -0.31 0.001 -0.31 9.2
Smoking 0.08 0.39 not entered < 4.0
Log Dmin (units) -0.30 0.001 -0.33 10.7
SRrs (cmH2O/L/sec/min) 0.28 0.003 not entered < 4.0
Adjusted R2 = 0.22, p < 0.0001 for the multivariate analysis of appearance of wheezes. Wheezes, atopy, and smoking status are rated as 0 for absent 
and 1 for present. Disease is labeled as 0 for cough variant asthma and 1 for classic asthma. F value is a measure of the extent to which a variable 
makes a unique contribution to the prediction of the dependent variable. Dmin, cumulative dose of inhaled methacholine at the inflection point, 
where which respiratory resistance begins to increase. SRrs, slope of the methacholine dose-response curve for respiratory resistance.
Table 3: Univariate and multivariate regression analyses of appearance of cough
Univariate analysis
Correlation coefficient
PC o u g h
Standardized partial regression coefficient
F value
Disease -0.20 0.036 -0.27 6.2
Blood eosinophils (number/μl) -0.12 0.27 Not entered < 4.0
Atopy 0.02 0.83 not entered < 4.0
Baseline FEV1/FVC (%) 0.11 0.25 not entered < 4.0
Smoking -0.10 0.30 not entered < 4.0
Log Dmin (units) 0.09 0.33 not entered < 4.0
SRrs (cmH2O/L/sec/min) -0.02 0.87 not entered < 4.0
Adjusted R2 = 0.06, p = 0.015 for the multivariate analysis of appearance of cough. Cough, atopy, and smoking status are rated as 0 for absent and 1 
for present. Disease is labeled as 0 for cough variant asthma and 1 for classic asthma. F value is a measure of the extent to which a variable makes a 
unique contribution to the prediction of the dependent variable. Dmin, cumulative dose of inhaled methacholine at the inflection point, where 
which respiratory resistance begins to increase. SRrs, slope of the methacholine dose-response curve for respiratory resistance.Cough 2009, 5:3 http://www.coughjournal.com/content/5/1/3
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have lead to a selection bias toward patients with more
severe CVA. In contrast, all subjects with CVA in the
present study were outpatients. Our subjects may there-
fore be more representative of patients encountered in
daily practice.
Several studies in children indicate that the degree of
excessive airway narrowing is modest in patients with
CVA. Yoo et al have shown that children with CVA more
frequently reach a maximal response plateau on the dose-
response curve to methacholine than those with classic
asthma [23]. Moreover, plateau levels are lower in chil-
dren with CVA [24]. In agreement with these results in
children with CVA [12,23,24], we demonstrated for the
first time that adults with CVA were significantly less reac-
tive to methacholine than were those with classic asthma,
although the difference in airway reactivity between the
two groups was small in our study of adults.
The presence or absence of cough and wheezes during
methacholine-induced bronchoconstriction was our
main interest. Bronchoconstriction is a well-known stim-
ulant of cough that is thought to be mediated by mech-
anosensitive, rapidly adapting receptors [25]. In a guinea
pig model of CVA, degree of antigen-induced bronchoc-
onstriction is strongly correlated with cough counts that
are inhibited by procaterol administration [26]. Clinical
studies examining the appearance of cough during bron-
choconstriction are scant, however. Springer et al. per-
formed methacholine provocation tests by the forced
expiration method in asthmatic children with wheezing
[13]. Cough appeared in most (81%) of the asthmatic
children, but the background characteristics of the cough-
ers were not described. We showed that the appearance of
cough was solely associated with a diagnosis of CVA and
not with mechanistic variables. It was also surprising that
only 17% of the adults with classic asthma coughed dur-
ing bronchoconstriction in our study. Mechanisms under-
lying the discrepancy in bronchoconstriction-induced
cough between classic asthma and CVA were not clarified
since cough sensitivity did not differ between the two
asthmatic conditions. However given that in CVA group
coughers had more heightened cough sensitivity to
inhaled capsaicin than non-coughers, cough during meth-
acholine-induced bronchoconstriction might be on a
background of enhanced capsaicin cough reflex in CVA.
However the guinea pig model of CVA described above is
not sensitive to inhaled capsaicin and the authors negate
the involvement of tachykinins in bronchoconstriction-
induced cough [26]. Further studies are necessary to eluci-
date a linkage between bronchoconstriction-triggered
cough and capsaicin-induced cough in CVA patients.
As expected, wheezes were more frequent in the classic
asthma group than in the CVA group at the end of meth-
acholine inhalation. In contrast to cough, wheezes were
not classic asthma-specific on multivariate analysis. Base-
line airflow obstruction and airway hypersensitivity con-
tributed to the presence of wheezes, consistent with the
theory that wheezes are generated by airflow turbulence
[27]. Mochizuki et al. proposed that lower airway reactiv-
ity or slower airway constriction may explain the absence
of wheezing or dyspnea in children with CVA [12]. We
found no independent contribution of airway hyperreac-
tivity to the appearance of wheezes. The lower frequency
of wheezes in patients with CVA may be inherently related
to their better pulmonary function and modest airway
sensitivity.
Needless to say, airway inflammation has an important
role in the pathogenesis of both CVA and classic asthma.
Lack of the information on airway inflammation in the
present study may not weaken our results, however, since
methacholine contracts airway smooth muscle without
modulating airway inflammation. Methacholine provoca-
tion test may not reproduce clinical conditions, but we
believe that our findings regarding the frequency of cough
and wheezes triggered by airway smooth muscle contrac-
tion in classic asthma and CVA are novel and relevant.
One may argue that methacholine worked as a non-spe-
cific nociceptor stimulant for cough. However, given that
cough subsided after methacholine was switched to a
bronchodilator, we are convinced that cough was trig-
gered directly by bronchoconstriction. Another possible
limitation of this study was that wheezes were not auto-
matically detected. Albeit auscultation is less sensitive
than automatic analysis, their agreement is fairly good
[27], and auscultation was done in a constant and blinded
manner by either of the two examiners (HM, AN) to min-
imize bias.
Conclusion
In conclusion, there are mechanistic and phenotypic dif-
ferences between CVA and classic asthma during metha-
choline-induced bronchoconstriction. The milder
mechanistic impairment in patients with CVA may
explain their lower frequency of wheezing. Frequent
coughing triggered by bronchoconstriction was predomi-
nantly associated with CVA and was unrelated to mecha-
nistic variables. Our findings may provide important clues
to better understanding the unique features of CVA.
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